Archrock Inc
For the period ended Jun 30, 2024. Filed Jul 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 31, 2024
AROC$27.88-3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Six Months Ended | ||||||
| · · June 30, | ||||||
| · 2024 · 2023 | ||||||
| Cash flows from operating activities: · · · · | ||||||
| Net income | | $74,957 | | $41,138 | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | | | ||||
| Depreciation and amortization | | 86,688 | | 81,391 | ||
| Long-lived and other asset impairment | | 6,969 | | 5,461 | ||
| Unrealized change in fair value of investment in unconsolidated affiliate | | | — | | | 1,996 |
| Inventory write-downs | | 517 | | 359 | ||
| Amortization of operating lease right-of-use assets | | | 1,827 | | | 1,649 |
| Amortization of deferred financing costs | | | 2,323 | | | 3,468 |
| Amortization of debt premium | | | (1,003) | | | (1,003) |
| Amortization of capitalized implementation costs | | | 1,562 | | | 1,202 |
| Stock-based compensation expense | | 7,477 | | 6,524 | ||
| Provision for (benefit from) credit losses | | 5 | | (140) | ||
| Gain on sale of assets, net | | (2,957) | | (4,781) | ||
| Deferred income tax provision | | 24,900 | | 15,417 | ||
| Amortization of contract costs | | | 11,725 | | | 10,250 |
| Deferred revenue recognized in earnings | | | (5,606) | | | (8,754) |
| Changes in operating assets and liabilities: | | | | | ||
| Accounts receivable, net | | | 8,836 | | | (5,462) |
| Inventory | | | 2,073 | | | (6,642) |
| Other assets | | | (4,004) | | | (2,109) |
| Contract costs | | | (9,660) | | | (12,398) |
| Accounts payable and other liabilities | | | (4,661) | | | (16,102) |
| Deferred revenue | | | 6,315 | | | 7,106 |
| Other | | | 70 | | | (172) |
| Net cash provided by operating activities | | 208,353 | | 118,398 | ||
| | | | | | | |
| Cash flows from investing activities: | | | ||||
| Capital expenditures | | (191,026) | | (187,476) | ||
| Proceeds from sale of property, equipment and other assets | | 17,550 | | 38,093 | ||
| Proceeds from insurance and other settlements | | | 45 | | | 437 |
| Investments in unconsolidated entities | | | (57) | | | (2,000) |
| Net cash used in investing activities | | (173,488) | | (150,946) | ||
| | | | | | | |
| Cash flows from financing activities: | | | ||||
| Borrowings of long-term debt | | 485,825 | | 417,825 | ||
| Repayments of long-term debt | | (462,150) | | (327,300) | ||
| Payments of debt issuance costs | | — | | (5,528) | ||
| Dividends paid to stockholders | | (51,819) | | (47,356) | ||
| Repurchases of common stock | | | (1,230) | | | (2,073) |
| Taxes paid related to net share settlement of equity awards | | | (6,462) | | | (3,775) |
| Proceeds from stock issued under ESPP | | 552 | | 382 | ||
| Net cash provided by (used in) financing activities | | (35,284) | | 32,175 | ||
| Net decrease in cash and cash equivalents | | (419) | | (373) | ||
| Cash and cash equivalents, beginning of period | | 1,338 | | 1,566 | ||
| Cash and cash equivalents, end of period | | $919 | | $1,193 | ||
| | | | | | | |
Notes to Condensed Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.